CompoAtlas

MARY RUTH - 3-in-1 DAILY DIGESTIVE HEALTH CAPSULES

MARY RUTH - 3-in-1 DAILY DIGESTIVE HEALTH CAPSULES, NPN 80147302: natural health product licensed in Canada. Medicinal ingredients: Lacticaseibacillus rhamnosus, Bifidobacterium breve, Lactiplantibacillus plantarum, Bifidobacterium animalis subsp. lactis.

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Lacticaseibacillus rhamnosus

Source : GG

2 Milliards d'UFCNot calculated
Bifidobacterium breve

Source : Bb-18

0.1 Milliards d'UFCNot calculated
Bifidobacterium breve

Source : Bifidobacterium breve - Cellule entière

0.1 Milliards d'UFCNot calculated
Lactiplantibacillus plantarum

Source : KABP-022

1 Milliards d'UFCNot calculated
Bifidobacterium animalis subsp. lactis

Source : BLC1

0.5 Milliards d'UFCNot calculated
Bifidobacterium bifidum

Source : BB-06

1.8 Milliards d'UFCNot calculated
Bifidobacterium bifidum

Source : Bifidobacterium bifidum - Cellule entière

1.8 Milliards d'UFCNot calculated
Gomme de Guar partiellement hydrolysée

Source : Partially hydrolysed guar gum

100 mgNot calculated
Lactobacillus gasseri

Source : LG050

1 Milliards d'UFCNot calculated
Lacticaseibacillus Rhamnosus

Source : HN001

0.25 Milliards d'UFCNot calculated
Lacticaseibacillus Casei

Source : LC-11

2.5 Milliards d'UFCNot calculated
Bifidobacterium longum subsp. longum

Source : BL-04

1 Milliards d'UFCNot calculated
Pediococcus acidilactici

Source : KABP-021

1 Milliards d'UFCNot calculated
Pediococcus acidilactici

Source : Pediococcus acidilactici - Whole Cell

1 Milliards d'UFCNot calculated
Lactiplantibacillus plantarum

Source : DR7

1 Milliards d'UFCNot calculated
Lactiplantibacillus plantarum

Source : Lactiplantibacillus Plantarum - Cellule entière

1 Milliards d'UFCNot calculated
Lactococcus lactis

Source : Lactococcus lactis - Cellule entière

23.5 Milliards d'UFCNot calculated
Lactococcus lactis

Source : LI-23

23.5 Milliards d'UFCNot calculated
Lacticaseibacillus paracasei

Source : LPC-37

3 Milliards d'UFCNot calculated
Lactiplantibacillus plantarum

Source : LP-115

3.8 Milliards d'UFCNot calculated
Lactiplantibacillus plantarum

Source : Lactiplantibacillus Plantarum - Cellule entière

3.8 Milliards d'UFCNot calculated
Bifidobacterium longum subsp. longum

Source : BL-05

2 Milliards d'UFCNot calculated
Bifidobacterium longum subsp. longum

Source : Bifidobacterium longum subsp. longum - Cellule entière

2 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : La-14

2 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : Lactobacillus acidophilus - Cellule entière

2 Milliards d'UFCNot calculated
Limosilactobacillus reuteri

Source : PBS072

0.25 Milliards d'UFCNot calculated
Limosilactobacillus reuteri

Source : LR100

0.25 Milliards d'UFCNot calculated
Bifidobacterium longum subsp. infantis

Source : Bifidobacterium longum subsp. Infantis - Whole Cell

0.1 Milliards d'UFCNot calculated
Bifidobacterium longum subsp. infantis

Source : Bi-26

0.1 Milliards d'UFCNot calculated
Lactiplantibacillus plantarum

Source : KABP-023

1 Milliards d'UFCNot calculated
Bifidobacterium longum subsp. longum

Source : Bifidobacterium longum subsp. longum - Cellule entière

1 Milliards d'UFCNot calculated
Ligilactobacillus salivarius

Source : Ls-33

0.1 Milliards d'UFCNot calculated
Levilactobacillus brevis

Source : Lbr-35

0.1 Milliards d'UFCNot calculated
Lacticaseibacillus Rhamnosus

Source : LRH020

5 mgNot calculated
Lactobacillus sakei

Source : proBio 65

13 mgNot calculated
Lactobacillus sakei

Source : proBio 65

1 Billion organismsNot calculated

Non-medicinal ingredients

Dextrose, Ascorbate de sodium, Cellulose microcristalline, Carbonate de magnésium, Sucrose, Phosphate de dipotassium, Phosphate de potassium monobasique, Chlorure de sodium, Maltodextrine, Hypromellose, Extrait de tige/feuille de Bambusa Vulgaris, D-Mannitol, L-Cystéine, Trehalose, Citrate de sodium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps to improve gut-related stress/discomfort in 6 weeks. Help improves quality of life in patients with diarrhea-predominant irritable bowel syndrome. Helps improve quality of life by relieving IBS symptoms. Helps reduce symptoms of lactose intolerance such as abdominal pain and flatulence. Helps relief symptoms of irritable bowel syndrome (IBS). Helps improve IBS-related quality of life in patients with IBS and diarrhea. Helps relieve the symptoms of irritable bowel syndrome (IBS) (abdominal pain, bloating, distension). Helps to manage patients' IBS symptoms that impacts their quality of life. Helps improve quality of life in IBS patients by supporting gut health and improving gut comfort. Helps to improve IBS gut-related stress/discomfort in 6 weeks. Supports a healthy lifestyle. Supports antioxidant capacity. Helps support a healthy digestive tract and healthy gut microflora. Helps support gut microbiome diversity. Provides live microorganisms that contribute to healthy digestive tract flora. Probiotic that contributes to healthy digestive tract flora. Probiotic that naturally forms part of the digestive tract flora. Provides live microorganisms that naturally form part of the digestive tract flora.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No warning text available in the imported data.

Product record

Licence holder
Les Emballages Façoteck
NPN or DIN-HM
80147302
Status
Active licence
Licence date
12 February 2026
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

Source

Official Health Canada record, licence 80147302

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “MARY RUTH - 3-in-1 DAILY DIGESTIVE HEALTH CAPSULES (Les Emballages Façoteck): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80147302-mary-ruth-3-in-1-daily-digestive-health-capsules, updated 12 February 2026.

Enter to analyse, Shift+Enter for a new line